Eczema Awareness Monthly – An American Academy of Dermatology Official Licensee
0
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
0
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Advertisement
EczemaStudies

Cancer incidence in children using topical tacrolimus for atopic dermatitis

Awareness Monthly
Posted by Awareness Monthly

The incidence of lymphoma and other cancers was studied in pediatric patients taking topical calcineurin inhibitors to treat atopic dermatitis.

Learn more at the Journal of the American Academy of Dermatology.

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Awareness Monthly
Previous Article The impact of dupilumab on itch in atopic dermatitis
Next Article Perceived clinical severity of atopic dermatitis in adolescents: comparison between patients’ and parents’ evaluation
Advertisement

 

Advertisement

 

You Might Also Enjoy

ArticlesEczema

First Topical JAK Inhibitor for Atopic Dermatitis Receives FDA Approval

ArticlesEczema

Pediatric Atopic Dermatitis: Topical Calcineurin Inhibitors

ArticlesEczema

Atopic Dermatitis and COVID-19 Infection Risk

ArticlesEczema

Biologic for Atopic Dermatitis FDA Approved

Load More
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee

© 2020-2023 Powered by eHealthcare Solutions | Privacy Policy

×